Effects of a Multispecies Probiotic Mixture on Glycemic Control and Inflammatory Status in Women with Gestational Diabetes: A Randomized Controlled Clinical Trial
Table 1
Baseline characteristics of the intention-to-treat population.
Variables
Probiotic group ()
Control group ()
value
Age (year)
32.4 ± 3.1
31.9 ± 4.0
0.20
Height (cm)
162.1 ± 4.8
160.9 ± 4.6
0.27
BMI (kg/m2)
26.8 ± 2.7
27.4 ± 3.1
0.19
Oral glucose tolerance test values (mmol/L)
Fasting glucose
5.2 ± 0.6
4.9 ± 0.7
0.34
1-hour glucose
11.8 ± 1.3
11.1 ± 1.6
0.33
2-hour glucose
10.4 ± 1.2
10.2 ± 1.4
0.39
3-hour glucose
7.8 ± 1.8
7.6 ± 1.6
0.46
Prepregnancy weight (kg)
70.4 ± 7.3
69.8 ± 9.2
0.37
Weight at study baseline (kg)
72.9 ± 6.6
73.3 ± 8.6
0.47
Parity ≥ 1 (N)
16
15
0.64
Gestational age (weeks)
26.4
26.6
0.49
Weight at end of trial (kg)
74.9 ± 7.7
75.3 ± 8.3
0.34
BMI, body mass index; data are the means ± SD; obtained from an independent -test.
